Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Express Company (AXP), Rockwell Collins Inc. (COL) & More: Here’s Why These Stocks Are Trending Today

Page 1 of 2

Markets shrugged off the negative trend and are trading well in the green today amid news that World Trade Organization’s has slashed its world trade forecast to the lowest since global financial crisis.

Meanwhile, a number of stocks are in the spotlight in connection with different developments. Among these stocks are American Express Company (NYSE:AXP), Rockwell Collins Inc. (NYSE:COL), Mylan NV (NASDAQ:MYL), Juno Therapeutics Inc. (NASDAQ:JUNO), and Novo Nordisk (ADR) (NYSE:NVO). Let’s take a closer look at the news impacting these stocks and see what the investors from our database think about them.

An everyday investor doesn’t have the same resources and capabilities to analyze different publicly-traded companies as hedge funds do. This is why it is a good idea to see what stocks hedge funds like the most and try to imitate some of their bullish moves in an attempt to reap market-beating returns. At Insider Monkey, we follow the activity of several hundred of the best-performing hedge funds as part of our strategy. We analyze their 13F filings and use the data to see what stocks they are collectively bullish on. Through extensive research we have determined that the best approach to outperform the broader indices is to follow hedge funds into their top small-cap ideas. In our backtests, a portfolio of the 15 most popular small-cap stocks generated monthly alpha of 81 basis points, versus 0.7 percentage points posted by hedge funds’ top large- and mega-cap picks (see more details here).

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,


American Express Company (NYSE:AXP) has announced increase in its dividend earlier today. The company will now pay a quarterly dividend of $0.32 per share, up by 10%. In addition, American Express Company has approved a new buyback program of 150 million shares, which replaces its earlier plan which still had about 50 million shares remaining. Among the funds we track, 48 funds held $12.59 billion worth of American Express Company’s stock in aggregate at the end of June, having amassed 21.80% of its outstanding stock; there’s not been much change from the previous quarter.

Follow American Express Co (NYSE:AXP)
Trade (NYSE:AXP) Now!

Rockwell Collins Inc. (NYSE:COL) is in the spotlight after the company reported a new agreement signed with Stellar Labs, under the terms of which both companies will co-develop a cloud-based platform offering an end-to-end aircraft management solution through mobile devices, tablets and web browsers, Rockwell said in a statement. This disruptive technology is based on Rockwell Collins’ ARINCDirect® Flight Operations System (FOS®) and will replace the currently disparate storage methodology of aviation systems. The number of funds from our hedge fund database long Rockwell Collins was at 17 in the quarter ending June. The total value of their holdings stood at $77 million, in comparison to $120 million held by 18 funds at the end of previous quarter. This is almost 0.70% of its outstanding stocks.

Follow Rockwell Collins Inc (NYSE:COL)
Trade (NYSE:COL) Now!

Mylan NV (NASDAQ:MYL) yesterday admitted that its profit for EpiPens is higher than what it reported to Congress earlier. In a statement, the company said that its actual pre-tax profits are 60% higher than the numbers presented to the Congress. Mylan has been mired in controversy after Hillary Clinton spoke against price gouging tactics in the pharma industry, especially EpiPen’s exorbitant price as a delivery system of a low cost drug. A total of 44  funds from our database have positions in Mylan with a total value of $196 million as of the end of June, which represents about 9% of its outstanding stock.

Follow Mylan Inc. (NASDAQ:MYL)
Trade (NASDAQ:MYL) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!